More importantly, the proportions of tumor‐infiltrating IFNγ+, GZMB+, and TNFα+ CD8+ T cells were significantly elevated after SRC‐1 deletion, indicating more effector CD8+ T cells were activated. The gene discussed is CD8A; the disease is neoplasm.